Psychiatric Group Faces Scrutiny Over Drug Industry Ties
It seemed an ideal marriage, a scientific partnership that would attack mental illness from all sides. Psychiatrists would bring to the union their expertise and clinical experience, drug makers would provide their products and the money to run rigorous studies, and patients would get better medications, faster.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment